DoW Orthopaedic, Clinical Research Award — HT942526ORPCRA

FundingApproximately $13.6 million total program funding; approximately 5 awards. Research Level 1 total-cost cap: $2.0 million per award. Research Level 2 total-cost cap: $3.2 million per award. Maximum 4-year period of performance. No cost sharing required.

DeadlineMandatory preproposal: August 19, 2026 at 5:00 PM Eastern Time. Invitation date: September 25, 2026. Full application: November 18, 2026 at 11:59 PM Eastern Time. Verification ends November 23, 2026 at 5:00 PM Eastern Time.

Last verifiedOctober 7, 2026

Required next actionCurrent-cycle applicants must have submitted the mandatory August 19 preproposal and received an invitation to submit a full application. Verify invitation status, qualified clinical-research leadership, military relevance, study-population access, regulatory readiness, and the applicable Research Level and focus area before preparing the invited application.

Broad Eligibility

Domestic and foreign for-profit and nonprofit organizations and public/private entities are eligible, subject to the program announcement. Independent investigators affiliated with eligible organizations may serve as PI. Cost sharing is not required. Current-cycle progression requires a timely mandatory preproposal and invitation.

Atlas Analysis

Atlas Opportunity Score 91/100. Preferred posture: Partner-Led / Already-Preapplied Orthopaedic Clinical Research Team. Research Level 1 supports clinical research in designated focus areas, while Research Level 2 supports clinical trials in designated focus areas. Structural eligibility alone does not establish submission readiness; a credible pursuit requires a timely preproposal, invitation, appropriate orthopaedic clinical expertise, military relevance, infrastructure, population access, and regulatory readiness.

Federal opportunity identifier: HT942526ORPCRA

The FY26 Orthopaedic Clinical Research Award supports clinical research and clinical trials addressing priority military orthopaedic needs. Research Level 1 supports clinical research, while Research Level 2 supports clinical trials. The announcement identifies focus areas including ligamentous trauma, osseointegration outcomes, return-to-duty strategies, military women’s health, and limb stabilization and protection, depending on research level.

Funding: Approximately $13.6 million total. About two Research Level 1 awards are anticipated with a $2.0 million total-cost cap per award, and about three Research Level 2 awards are anticipated with a $3.2 million total-cost cap per award. Maximum period of performance is four years. Cost sharing is not required.

Current-cycle deadlines: The mandatory preproposal deadline was August 19, 2026 at 5:00 PM Eastern Time. Invitations are scheduled for September 25, 2026. Invited full applications are due November 18, 2026 at 11:59 PM Eastern Time.

Because the mandatory first-stage deadline has passed, current-cycle support is restricted to teams that submitted a timely preproposal and, after September 25, receive an invitation. New FY26 applicant outreach should not be initiated for this mechanism.

Source verificationOfficial government source · simpler.grants.govAtlas last verified this record October 7, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗